Dialog Box

Loading...
08
Mar
2019

Dr Yenson joins Cure Brain Cancer Foundation to help find a cure faster


Dr Vanessa Yenson

Dr Vanessa Yenson is a cancer survivor, scientist, clinical research expert and now, Cure Brain Cancer Foundation’s Research Operations Manager. Following an esteemed career in research and science, Vanessa will oversee the Foundation’s research expenditure, manage its relationships with the incredible brain cancer research community around the world, and help achieve its mission of improving brain cancer survival to 50% by 2023. We are delighted to welcome Vanessa to the Foundation. 

Vanessa was the first adult in Australia to receive a bone marrow transplant from cord blood in 1999 after her leukaemia relapsed. The experience of her life being saved by medical research has motivated the choices she has made in her career since.

"My personal experience with cancer has been my motivation to help others who are in a similar situation. My ultimate objective is to give back to the field of that saved my life and to help save the lives of others." 

After receiving a Bachelor of Health Science in Hearing and Speech in 2002, Vanessa refocused, undertaking a Bachelor of Science in Biomedical Science (Hons) to help try to drive the types of medical breakthroughs that saved her life. She graduated with first-class honours and the University Medal and went on to achieve a Doctorate (PhD) in Reproductive Immunology.

Her professional career has driven her into medical research both in Sydney and overseas at University of California, Davis. Recent years have seen her move away from the laboratory and into the world of clinical research and trials, where she has excelled.

Vanessa addresses the Rally for Research in 2011. 

Vanessa is also an esteemed public speaker, media commentator, university guest lecturer and passionate volunteer for causes including the Australian Red Cross Blood Service. We are delighted to welcome Vanessa to Cure Brain Cancer Foundation and look forward to introducing her to the Australian brain cancer community as she settles in to the role.

Help fund vital brain cancer research